OXYGENTA PHARMACEUTICAL
Back to All Ratios
|
OXYGENTA PHARMACEUTICAL Last 5 Year Price to Cash Earnings (PCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | -33.18 | -118.58 | -5.46 | 34.82 | - |
What is the latest Price to Cash Earnings (PCE) ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | -33.18 |
| Mar2024 | -118.58 |
| Mar2023 | -5.46 |
| Mar2022 | 34.82 |
| Mar2021 | - |
How is Price to Cash Earnings (PCE) of OXYGENTA PHARMACEUTICAL Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | -33.18 | Negative | |
| Mar2024 | -118.58 | Negative | |
| Mar2023 | -5.46 | Negative | |
| Mar2022 | 34.82 | 0 | |
| Mar2021 | 0 | - | |
Other Financial Ratios of OXYGENTA PHARMACEUTICAL
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹201.8 Cr | -1.7% | -8.4% | -40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,131.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,862.0 Cr | 2.9% | 1.8% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,254.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹121,198.0 Cr | 0.2% | -0.2% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,083.0 Cr | 0.9% | 4.8% | -3.2% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -1.7% |
-8.4% |
-40.2% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses